Advances in histone demethylase KDM3A as a cancer therapeutic target

J Yoo, YH Jeon, HY Cho, SW Lee, GW Kim, DH Lee… - Cancers, 2020 - mdpi.com
Lysine-specific histone demethylase 3 (KDM3) subfamily proteins are H3K9me2/me1
histone demethylases that promote gene expression. The KDM3 subfamily primarily consists …

Epigenetics and environment in breast cancer: New paradigms for anti-cancer therapies

C Thakur, Y Qiu, Y Fu, Z Bi, W Zhang, H Ji… - Frontiers in …, 2022 - frontiersin.org
Breast cancer remains the most frequently diagnosed cancer in women worldwide. Delayed
presentation of the disease, late stage at diagnosis, limited therapeutic options, metastasis …

Histone lysine dimethyl-demethylase KDM3A controls pathological cardiac hypertrophy and fibrosis

QJ Zhang, TAT Tran, M Wang, MJ Ranek… - Nature …, 2018 - nature.com
Left ventricular hypertrophy (LVH) is a major risk factor for cardiovascular morbidity and
mortality. Pathological LVH engages transcriptional programs including reactivation of …

Extracellular vesicles‐encapsulated let‐7i shed from bone mesenchymal stem cells suppress lung cancer via KDM3A/DCLK1/FXYD3 axis

J Liu, Y Feng, X Zeng, M He, Y Gong… - Journal of Cellular and …, 2021 - Wiley Online Library
Accumulating evidence has suggested that extracellular vesicles (EVs) play a crucial role in
lung cancer treatment. Thus, we aimed to investigate the modulatory role of bone marrow …

Targeting histone modifications in breast cancer: a precise weapon on the way

W Li, H Wu, S Sui, Q Wang, S Xu… - Frontiers in cell and …, 2021 - frontiersin.org
Histone modifications (HMs) contribute to maintaining genomic stability, transcription, DNA
repair, and modulating chromatin in cancer cells. Furthermore, HMs are dynamic and …

Crucial functions of the JMJD1/KDM3 epigenetic regulators in cancer

Y Sui, R Gu, R Janknecht - Molecular Cancer Research, 2021 - AACR
Epigenetic changes are one underlying cause for cancer development and often due to
dysregulation of enzymes modifying DNA or histones. Most Jumonji C domain-containing …

Roles of HIF and 2-oxoglutarate-dependent dioxygenases in controlling gene expression in hypoxia

J Frost, M Frost, M Batie, H Jiang, S Rocha - Cancers, 2021 - mdpi.com
Simple Summary Hypoxia—reduction in oxygen availability—plays key roles in both
physiological and pathological processes. Given the importance of oxygen for cell and …

Lysine demethylase KDM3A regulates nanophotonic hyperthermia resistance generated by 2D silicene in breast cancer

C He, L Yu, L Ding, H Yao, Y Chen, Y Hao - Biomaterials, 2020 - Elsevier
Breast cancer (BC) is the most common malignant disease affecting women's health
worldwide. The benefits from conventional therapeutic modalities are severely limited. An …

Opposite roles of the JMJD1A interaction partners MDFI and MDFIC in colorectal cancer

Y Sui, X Li, S Oh, B Zhang, WM Freeman, S Shin… - Scientific Reports, 2020 - nature.com
MyoD family inhibitor (MDFI) and MDFI domain-containing (MDFIC) are homologous
proteins known to regulate myogenic transcription factors. Hitherto, their role in cancer is …

[HTML][HTML] Dihydroartemisinin suppresses bladder cancer cell invasion and migration by regulating KDM3A and p21

T Wang, R Luo, W Li, H Yan, S Xie, W Xiao… - Journal of …, 2020 - ncbi.nlm.nih.gov
Emerging evidences have shown that Dihydroartemisinin (DHA), used in malaria treatment,
possess anti-cancer activity. However, the study of its potential functional roles and the anti …